Meet the Team
-
Sean Chen
Founder
CEO
-
Peter Butzloff Yang
Founder/Technology
-
Jesse Chen
Operations
-
Danny Yu
Community Partnerships
-
Simon Cao
Director of Strategy & Fundraising
-
Charles Mao
Business Development
-
Samuel Zia
Chief Medical Officer
Expertise-Driven Team
Pharmzandia has assembled a core team with expertise in neuroscience, nanomaterials, physics, marketing, operations, and senior community engagement. Our leadership team has a strong track record in technology commercialization, successfully guiding multiple startups to successful exits.
A Unique Approach
Unlike traditional pharmaceutical companies that focus heavily on chemistry and neuroscience, our team emphasizes nanotechnology, physics, and engineering. This allows us to take a more efficient and innovative approach by outsourcing standard pharmaceutical processes, minimizing development risks while focusing on cutting-edge therapeutic design.
Engineering-Based Drug Development
We apply concurrent engineering methodologies to develop nanomedicine solutions, treating drug development more like a precision-engineered process—similar to how chips are designed in the semiconductor industry. This unique strategy enables us to develop highly effective therapeutic solutions with increased efficiency and accuracy.
By leveraging our expertise and strategic approach, Pharmzandia is positioned to drive the future of nanomedicine and transform the landscape of neurological treatments.